At the 2015 European Congress of Radiology (ECR 2015), Esaote introduced Evolution’15 (EVO’15) as the latest upgrade in its dedicated magnetic resonance imaging (MRI) Evolution program. EVO’15 combines software updates and new hardware features to provide high image quality and increases productivity by almost 50 percent.

Physicians treating patients with complex tumors will have more advanced treatment options at Seattle Cancer Care Alliance Proton Therapy, a ProCure Center. The center will now offer pencil beam scanning (PBS) in its state-of-the-art gantry room. The combination of proton therapy with PBS technology enables physicians to better shape and direct radiation to the tumor, opening the doors to treat a wider variety of cancers.

For the third consecutive year, a Dolbey speech recognition solution was named Best in KLAS. Dolbey earned this year’s Best in KLAS award for its Fusion SpeechEMR front-end speech software. In addition, Dolbey’s back-end speech product, Fusion Speech, earned the 2014 KLAS Category Leader award for the Speech Recognition, Back End category. Dolbey’s Fusion Suite includes speech recognition, dictation, transcription, core measures and coding solutions.

Accuray Inc. and Lancaster General Health announced that the first commercially available InCise multileaf collimator (MLC) for the CyberKnife M6 System has been received by Lancaster. The hospital selected the InCise MLC based on its ability to increase the system's treatment efficiency and extend its unique capabilities to a broader range of patient cases.

smoking, lung cancer, CT screening, guidelines

A decline in smoking rates may mean that many people who could have benefited from early detection of lung cancer are dying because they don’t qualify for low-dose computed tomography (CT) scans, according to a group of Mayo Clinic researchers. Their research appears in the Feb. 24 issue of JAMA, the journal of the American Medical Association.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now